FDA: District Court Should Dismiss Mifepristone Case; Intervening States Say No
AMARILLO, Texas — Parties in a lawsuit challenging the U.S. Food and Drug Administration’s approval of abortion drug mifepristone offered the district court varying opinions on how to proceed in light...To view the full article, register now.
Already a subscriber? Click here to view full article